June 1st 2023
Miebo is the first and only prescription eye drop approved for dry eye disease (DED) that directly targets tear evaporation.
Rollercoaster of Hospital COVID Drug Spending Continued in 2022May 10th 2023
Using a national database, data on medication purchases was collected, along with factors that may have influenced expenditures, such as new therapy availability, patent expirations, policy changes, and legislation.
Analyzing Cost-effectiveness Thresholds Over TimeMay 5th 2023
Cancer-related cost-effective analyses (CEA) referenced higher thresholds than non-cancer-related CEAs, which may suggest interventions for diseases associated with greater mortality and morbidity warrant higher thresholds.
FDA Approves First Fecal Microbiota Pill for Recurrent C. diff InfectionApril 28th 2023
CDI is a leading cause of infections acquired in healthcare settings, including hospitals and nursing homes. After recovering, individuals may get the infection again, and the risk of recurrence increases with each infection.
Express Scripts Expands Independent Pharmacy in Rural HealthcareApril 20th 2023
The expansion offers increased reimbursement opportunities and additional care services to rural independent pharmacies. In addition, it creates an Independent Pharmacy Advisory Committee to expand the role of rural, suburban and urban pharmacies in the healthcare system.
FDA Approves Omisirge to Reduce Infection Risk in Blood Cancer Patients Undergoing Stem Cell TransplantApril 19th 2023
Omisirge is a stem cell therapy that helps the body recover more quickly from cancer treatments that kill normal blood cells along with blood cancer cells, thus lowering the risk of infection.
New Express Scripts Programs Aim to Boost Affordability, TransparencyApril 13th 2023
Through Express Scripts’ new Copay Assurance plan, consumers will have lower out-of-pocket costs because of caps on prescription drugs: $5 for generics, $25 for preferred brand drugs, and $45 for preferred specialty brand drugs.
FDA Wants More Information about AbbVie’s Parkinson’s TherapyMarch 22nd 2023
In a complete response letter, the FDA has requested information about the pump that will be used to deliver ABBV-951, which will provide continuous subcutaneous delivery of oral immediate-release carbidopa/levodopa.
FDA Greenlights Generic Leukemia TreatmentMarch 10th 2023
Other news includes the launches of the first generic of an ulcer drug, the antipsychotic lurasidone, an extended-release version of topiramate for migraine, and additional strengths of the cancer drug lenalidomide. Additionally, Glenmark will distribute Cediprof's generic Adderall, and the FDA has accepted Amneal’s application for a generic naloxone nasal spray.